Atossa Therapeutics Inc (NASDAQ:ATOS) announced it has appointed Jonathan Finn to its board of directors, effective November 8, 2023. The company noted that.
Atossa Therapeutics (ATOS) Appoints Jonathan Finn to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will be issuing its quarterly earnings data on Monday, November 6th. Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) last posted its quarterly earnings results on Monday, August 14th. The company reported ($0.06) EPS for the quarter, hitting analysts’ consensus estimates of ($0.06). On average, analysts expect Atossa Therapeutics […]
Atossa Therapeutics Inc (NASDAQ:ATOS) s selective estrogen receptor modulator (Z)-endoxifen is being evaluated in a Phase 2 study aimed at preventing the.